Aiforia Technologies PLC equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services plan to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more.
2018
75
LTM Revenue $3.6M
LTM EBITDA -$8.5M
$104M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Aiforia has a last 12-month revenue of $3.6M and a last 12-month EBITDA of -$8.5M.
In the most recent fiscal year, Aiforia achieved revenue of $3.1M and an EBITDA of -$8.1M.
Aiforia expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Aiforia valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $2.6M | $3.1M | XXX | XXX | XXX |
Gross Profit | $2.0M | $2.1M | XXX | XXX | XXX |
Gross Margin | 78% | 68% | XXX | XXX | XXX |
EBITDA | -$10.3M | -$8.1M | XXX | XXX | XXX |
EBITDA Margin | -399% | -263% | XXX | XXX | XXX |
Net Profit | -$11.4M | -$13.9M | XXX | XXX | XXX |
Net Margin | -442% | -453% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Aiforia's stock price is EUR 4 (or $4).
Aiforia has current market cap of EUR 102M (or $109M), and EV of EUR 96.6M (or $104M).
See Aiforia trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$104M | $109M | XXX | XXX | XXX | XXX | $-0.43 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Aiforia has market cap of $109M and EV of $104M.
Aiforia's trades at 28.5x LTM EV/Revenue multiple, and -12.2x LTM EBITDA.
Analysts estimate Aiforia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Aiforia and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $104M | XXX | XXX | XXX |
EV/Revenue | 33.9x | XXX | XXX | XXX |
EV/EBITDA | -12.9x | XXX | XXX | XXX |
P/E | -8.5x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -7.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAiforia's NTM/LTM revenue growth is 63%
Aiforia's revenue per employee for the last fiscal year averaged $41K, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Aiforia's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Aiforia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Aiforia and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 19% | XXX | XXX | XXX | XXX |
EBITDA Margin | -263% | XXX | XXX | XXX | XXX |
EBITDA Growth | -21% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -200% | XXX | XXX | XXX | XXX |
Revenue per Employee | $41K | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 51% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 19% | XXX | XXX | XXX | XXX |
Opex to Revenue | 507% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
Healius | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aiforia acquired XXX companies to date.
Last acquisition by Aiforia was XXXXXXXX, XXXXX XXXXX XXXXXX . Aiforia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Aiforia founded? | Aiforia was founded in 2018. |
Where is Aiforia headquartered? | Aiforia is headquartered in Finland. |
How many employees does Aiforia have? | As of today, Aiforia has 75 employees. |
Is Aiforia publicy listed? | Yes, Aiforia is a public company listed on HEL. |
What is the stock symbol of Aiforia? | Aiforia trades under AIFORIA ticker. |
When did Aiforia go public? | Aiforia went public in 2021. |
Who are competitors of Aiforia? | Similar companies to Aiforia include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
What is the current market cap of Aiforia? | Aiforia's current market cap is $109M |
What is the current revenue of Aiforia? | Aiforia's last 12-month revenue is $3.6M. |
What is the current EBITDA of Aiforia? | Aiforia's last 12-month EBITDA is -$8.5M. |
What is the current EV/Revenue multiple of Aiforia? | Current revenue multiple of Aiforia is 28.5x. |
What is the current EV/EBITDA multiple of Aiforia? | Current EBITDA multiple of Aiforia is -12.2x. |
What is the current revenue growth of Aiforia? | Aiforia revenue growth between 2023 and 2024 was 19%. |
Is Aiforia profitable? | Yes, Aiforia is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.